IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis

Clinical trial NCT00488839 · COMPLETED

Trial details

NCT number: NCT00488839
Sponsor: Impax Laboratories, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2007-06-01
Primary completion: 2008-05-01
Enrollment: 173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.